iRhythm price target lowered to $198 from $212 at Canaccord

Canaccord lowered the firm’s price target on iRhythm (IRTC) to $198 from $212 and keeps a Buy rating on the shares. The firm said they reported Q4 revenue of $208.9M which was ahead of its early January preannouncement of $201.8M and consistent with Canaccord’s updated model, which had incorporated the company’s prior disclosure. They note the 2026 guidance was reiterated which was previously provided in January.